Venture Capital firm Norwest Venture Partners offloaded 9.3 per cent stake in diagnostics chain Thyrocare Technologies for an estimated over Rs 335 crore through open market transactions.
The shares were picked by Reliance Mutual Fund and Birla Sunlife Mutual Fund, among others.
According to bulk deal data available with BSE, Norwest Venture Partners VII-A-Mauritius offloaded a total of 50 lakh shares, or 9.30 per cent stake, of Thyrocare Technologies.
The shares were sold on in a price range of Rs 670- 670.88 apiece, valuing the transaction at Rs 335.22 crore.
As of June quarter, the venture capital firm owned 50,64,880 shares amounting to 9.43 per cent stake in the diagnostics chain.
Norwest Venture Partners is a global venture capital and growth equity investment firm that manages more than USD 6 billion in capital.
Reliance MF purchased 11.3 lakh shares of Thyrocare Technologies for Rs 75.71 crore (rpt) crore, while Birla Sunlife MF bought 10 lakh scrips of the diagnostics chain for Rs 67 crore. The shares were picked up by them on an average price of Rs 670.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
